First Manhattan’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

First Manhattan’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-230,300	Closed	-$4.7M	–	1543
2016 Q1	$4.7M	Buy	+230,300	New	+$7.31M	0.03%	240

Other funds holding PTLA

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Manhattan's PTLA Position: Q2 2016 in Review

First Manhattan sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2016, closing a stake of 230,300 shares — an estimated $4.7M sold.

First Manhattan first reported a position in PTLA in Q1 2016 and held it in 1 quarter. The position peaked at $4.7M in Q1 2016. 159 funds tracked by Wall St. Rank hold PTLA as of Q2 2016.

First Manhattan reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
First Manhattan sold 230,300 Portola Pharmaceuticals, Inc. shares in Q2 2016, an estimated $4.7M.
First Manhattan first reported a position in Portola Pharmaceuticals, Inc. in Q1 2016 and held it in 1 quarter.
First Manhattan's Portola Pharmaceuticals, Inc. position peaked at $4.7M in Q1 2016.
159 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2016.

Based on First Manhattan's 13F filing for Q2 2016, filed 14 Jul 2016.